首页> 外国专利> AUTOANTIBODIES BINDING TO NEGATIVE ELONGATION FACTOR E (NELF-E) FOR DIAGNOSING SARCOIDOSIS

AUTOANTIBODIES BINDING TO NEGATIVE ELONGATION FACTOR E (NELF-E) FOR DIAGNOSING SARCOIDOSIS

机译:与阴性延伸因子E(NELF-E)结合的自体抗体,用于诊断SARS

摘要

The present inventions relates generally to methods for diagnosing the presence or the risk of development or the therapy control of sarcoidosis in a subject, in particular, in mammals. In addition, the present invention relates to test kits for use in the diagnosis of the presence or the risk of development, or for the therapy control of sarcoidosis in a subject. In particular, the present invention relates to a method for diagnosing the presence or the risk of development, or for the therapy control of sarcoidosis in a subject analyzing for the presence of antibodies against NELF-E or immunoreactive peptides thereof or NELF-E analog protein, preferably bacterial analog protein, or immunoreactive peptides thereof, in a subject. The presence of antibodies against NELF-E or immunoreactive peptides thereof, is indicative for the presence or the risk of development, or for the therapy control of sarcoidosis. In particular, detection of the presence of antibodies against sarcoidosis or immunoreactive peptides thereof, allows early diagnosis of sarcoidosis.
机译:本发明总体上涉及用于诊断对象,尤其是哺乳动物中结节病的发展或治疗控制的存在或风险的方法。另外,本发明涉及用于诊断受试者中结节的存在或风险或用于治疗结节病的治疗控制的测试试剂盒。特别地,本发明涉及一种用于诊断受试者中结节病的存在或发展的风险的方法,或者用于治疗结节病的治疗控制的方法,该方法分析针对NELF-E的抗体或其免疫反应性肽或NELF-E类似物蛋白的存在。在受试者中,优选细菌类似蛋白或其免疫反应性肽。针对NELF-E的抗体或其免疫反应性肽的存在表明存在或存在发展风险,或表明结节病的治疗控制。特别地,检测针对结节病的抗体或其免疫反应性肽的存在允许早期诊断结节病。

著录项

  • 公开/公告号WO2020035123A1

    专利类型

  • 公开/公告日2020-02-20

    原文格式PDF

  • 申请/专利权人 BAERLECKEN NIKLAS;

    申请/专利号WO2018EP71843

  • 发明设计人 BAERLECKEN NIKLAS;

    申请日2018-08-11

  • 分类号C07K16/30;G01N33/543;

  • 国家 WO

  • 入库时间 2022-08-21 11:13:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号